跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NATRAGESIC - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
NATRAGESIC
Approved
STANDARD
NATRAGESIC
J.M. TOLMANN LABORATORIES, INC.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e19cd55fa6ca0256
Company
J.M. TOLMANN LABORATORIES, INC.
Type
Standard
Approval Details
Approval Id
e19cd55fa6ca0256
Drug Approval Philippines Name
NATRAGESIC
Product Name
NATRAGESIC
Registration Number
DR-XY46056
Brand Name
NATRAGESIC
Generic Name
PARACETAMOL
Dosage Form
Suspension
Dosage Strength
250mg/ 5mL
Manufacturer
J.M. TOLMANN LABORATORIES, INC.
Issuance Date
28 September 2022
Expiry Date
02 October 2027
Pharmacologic Category
ANALGESIC/ANTIPYRETIC
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e19cd55fa6ca0256
Type
Standard
Back to Philippines FDA Approvals